CureVac N.V. is a biopharmaceutical company revolutionizing the field of mRNA-based vaccines and therapeutics. With a focus on developing innovative solutions for diseases ranging from infectious diseases to cancer, CureVac is at the forefront of personalized medicine. With its proprietary technology, the company is poised to transform the future of healthcare.
